EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Novel non‐invasive molecular signatures for oral cavity cancer, by whole transcriptome and small non‐coding RNA sequencing analyses: Predicted association with PI3K / AKT / mTOR pathway

Dimitra P Vageli iD, Panagiotis G Doukas iD, Jeffrey P Townsend, Curtis Pickering, Benjamin L Judson

Cancer Medicine · 2024

DOI: 10.1002/cam4.7309 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2024. Verfasst von Dimitra P Vageli und 4 weiteren Autor:innen. Beteiligte Einrichtung: Yale Larynx Lab, Surgery Otolaryngology, Yale School of Medicine, New Haven, Connecticut, USA. Hauptthemen laut MEDLINE: Mouth Neoplasms, TOR Serine-Threonine Kinases, Proto-Oncogene Proteins c-akt, Biomarkers, Tumor. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Identification of molecular biomarkers in the saliva and serum of oral cavity cancer patients represents a first step in the development of essential and efficient clinical tools for early detection and post‐treatment monitoring. We hypothesized that molecular analyses of paired saliva and serum samples from an individual would likely yield better results than analyses of either serum or saliva alone. Materials and Methods We performed whole‐transcriptome and small non‐coding RNA sequencing analyses on 32 samples of saliva and serum collected from the same patients with oral squamous cell carcinoma (OSCC) and healthy controls (HC).

Results

We identified 12 novel saliva and serum miRNAs and a panel of unique miRNA and mRNA signatures, significantly differentially expressed in OSCC patients relative to HC (log2 fold change: 2.6 – 26.8; DE: 0.02 – 0.000001). We utilized a combined panel of the 10 top‐deregulated miRNAs and mRNAs and evaluated their putative diagnostic potential (>87% sensitivity; 100% specificity), recommending seven of them for further validation. We also identified unique saliva and serum miRNAs associated with OSCC and smoking history (OSCC smokers vs. never‐smokers or HC: log2 fold change: 22–23; DE: 0.00003–0.000000001). Functional and pathway analyses indicated interactions between the discovered OSCC‐related non‐invasive miRNAs and mRNAs and their targets, through PI3K/AKT/mTOR signaling.

Conclusion

Our data support our hypothesis that using paired saliva and serum from the same individuals and deep sequencing analyses can provide unique combined mRNA and miRNA signatures associated with canonical pathways that may have a diagnostic advantage relative to saliva or serum alone and may be useful for clinical testing. We believe this data will contribute to effective preventive care by post‐treatment monitoring of patients, as well as suggesting potential targets for therapeutic approaches.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mouth NeoplasmsTOR Serine-Threonine KinasesProto-Oncogene Proteins c-aktBiomarkers, TumorSalivaPhosphatidylinositol 3-KinasesMicroRNAsSignal TransductionHumansFemaleMaleMiddle AgedTranscriptomeGene Expression Regulation, NeoplasticGene Expression ProfilingAgedRNA, Small UntranslatedAdultCase-Control StudiesSequence Analysis, RNARNA, MessengerCarcinoma, Squamous Cell

Stichwörter der Autor:innen

PI3K/AKT/mTORbiomarkersmRNAmiRNAoral canceroral squamous cell carcinomasmall non‐coding RNA sequencingwhole transcriptome sequencing

Substanzen

TOR Serine-Threonine KinasesProto-Oncogene Proteins c-aktBiomarkers, TumorPhosphatidylinositol 3-KinasesMTOR protein, humanMicroRNAsRNA, Small UntranslatedRNA, Messenger

Autor:innen und Institutionen

  • Yale Larynx Lab, Surgery Otolaryngology, Yale School of Medicine, New Haven, Connecticut, USA.
  • Department of Medicine, Saint Peter's University Hospital/Rutgers- RWJ Medical School, New Brunswick, New Jersey, USA.
  • Department of Biostatistics, Yale School of Public Health, New Haven, Connecticut, USA.
  • Department of Surgery, Division of Otolaryngology, Yale Medical School, New Haven, Connecticut, USA.

ORCID-Profile: Dimitra P Vageli, Panagiotis G Doukas

Förderung

  • NIH HHS

Zitieren

APA

Vageli, D. P., Doukas, P. G., Townsend, J. P., Pickering, C., & Judson, B. L. (2024). Novel non‐invasive molecular signatures for oral cavity cancer, by whole transcriptome and small non‐coding RNA sequencing analyses: Predicted association with PI3K / AKT / mTOR pathway. Cancer Medicine. https://doi.org/10.1002/cam4.7309

Vancouver

Vageli DP, Doukas PG, Townsend JP, Pickering C, Judson BL. Novel non‐invasive molecular signatures for oral cavity cancer, by whole transcriptome and small non‐coding RNA sequencing analyses: Predicted association with PI3K / AKT / mTOR pathway. Cancer Medicine. 2024. doi:10.1002/cam4.7309

BibTeX
@article{Vageli2024,
  author = {Vageli, Dimitra P and Doukas, Panagiotis G and Townsend, Jeffrey P and Pickering, Curtis and Judson, Benjamin L},
  title = {Novel non‐invasive molecular signatures for oral cavity cancer, by whole transcriptome and small non‐coding RNA sequencing analyses: Predicted association with PI3K / AKT / mTOR pathway},
  journal = {Cancer Medicine},
  year = {2024},
  doi = {10.1002/cam4.7309}
}
Kostenlos starten →